Галантамин фармацевтического сырья для мозга улучшает CAS 357-70-0
Описание
КЕЙС:357-70-0
MF:C17H21NO3
МВт:287.35
EINECS:1308068-626-2
Характеристики
Температура плавления:119-1210InChI=1/C25H36O3/c1-3-4-5-6-7-24
alpha D20 -118.8° (c = 1.378 in ethanol)
Точка кипения:429.65° C (Boldenone Series Boldenone Base для увеличения мышечной массы)
Плотность 1.0662 (Boldenone Series Boldenone Base для увеличения мышечной массы)
Boldenone Series Boldenone Base для увеличения мышечной массы 1.5022 (Boldenone Series Boldenone Base для увеличения мышечной массы)
температура хранения. -20Boldenone Series Boldenone Base для увеличения мышечной массы
Описание
Galantamine is used for the treatment of mild to moderate Alzheimer’s disease and various other memory impairments, in particular those of vascular origin. In addition to uses in Alzheimer’s disease, galantamine has been used to treat myasthenia, myopathy, muscular dystrophy, and sensory and motor dysfunction associated with disorders of the central nervous system. Research has indicated that galantamine may prove useful both in the treatment of organophosphate poisoning and in the treatment of autism in children and adolescents.
Болденон действует как орто-энолол с меньшим неблагоприятным воздействием на андрогены.
1. Galanthamine is alkaloid which is extracted from Amaryllidaceae plants Lycoris squamigera Maxim or Lycoris aurea,it is a reversible anti-cholinesterase drug, it is easy for it to go through the blood brain barrier into the brain tissue ,its effect on central nervous system is stronger.
2. it can improve neuromuscular conduction , compared with physostigmine, neostigmine , pyridostigmine , it has wide range of treatment, and low toxicity, muscarinic effects are weak and short-lived. Clinically Galanthamine is used not only for the treatment of myasthenia gravis, polio sequelae resting, but also for children with cerebral palsy, multiple neuritis, radiculitis and sensorimotor disorders caused by nervous system disease or trauma .
Превосходство
Yuanhang Bio-pharmaceutical Technology Co.,Ltd achieves millions of US dollars of salesrevenue in recent years. And there are currently over 400 employers, researchers accounting for 37%. We conducted more than 50 kinds of scientific research, and enjoy more than 20 national patents. We have even acquired national invention patent certificate. 5, 184 products of us are almost unique around the world. Our company’s various raw chemical materials are of reliable quality, most of which conform to the requirements of FCC, USP and BP, it is mainly sold to pharmacy companies and health care companies abroad. Our target markets comprise of USA, Канада, Великобритания, Бразилия, Нидерланды, Ирландия, Новая Зеландия, Austria, Australia and so on.